Drugs / 123-I INER
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00316797 | Apr 2006 → Dec 2013 | neurodegenerative disease | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 123-I INER | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00316797 ↗ |
| Route | Intravenous | “Following bolus intravenous injection of 5 mCi of 123-I INER” NCT00316797 ↗ |